David P King's most recent trade in Illumina Inc was a trade of 2,072 Common Stock done at an average price of $144.8 . Disclosure was reported to the exchange on May 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Illumina Inc | David P King | Director | Grant, award, or other acquisition of securities at price $ 144.83 per share. | 21 May 2026 | 2,072 | 2,072 (0%) | 0% | 144.8 | 300,088 | Common Stock |
| Privia Health Group Inc | David P King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 8,463 | 50,775 | - | 0 | Common Stock, $0.01 par value per share | |
| Smith & Nephew PLC (ADR) | David P King | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 36.31 per share. | 18 Aug 2025 | 2,800 | 2,800 (0%) | 0% | 36.3 | 101,680 | Ords 0.20p |
| Privia Health Group Inc | David P King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,396 | 42,312 | - | 0 | Common Stock, $0.01 par value per share | |
| Privia Health Group Inc | David P. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 11,124 | 33,916 | - | 0 | Common Stock, $0.01 par value per share | |
| Privia Health Group Inc | David P. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 7,758 | 22,792 | - | 0 | Common Stock, $0.01 par value per share | |
| Privia Health Group Inc | David P. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,425 | 15,034 | - | 0 | Common Stock, $0.01 par value per share |